Ocean Technology Development Tank
NOAA's 2-million-liter ocean tank in La Jolla is solving a real crisis in marine survey science — here's…
Charles · Aug 24, 2026AI-powered drug repurposing: Finding new uses for existing molecules
AI drug repurposing raised $8.9B in 2024 with zero FDA approvals. Here's what the hype is missing —…
Charles · Aug 24, 2026Gene-Edited CAR T Expands Rare Disease Horizons
Gene-edited CAR T therapy is opening rare disease treatment in 2026. Here's what CRISPR, AEGIS, and off-the-shelf T…
Charles · Aug 16, 2026Veterans’ PTSD resolves with psychedelic therapy in small US study
A small US study found 9 of 12 veterans no longer had PTSD after psilocybin therapy. Here's what…
Charles · Aug 11, 2026GLP-1 drugs linked to 17% drop in worker sick leave, new economic study finds
A new study links GLP-1 drugs like Ozempic to a 17% drop in worker sick leave. Here's what…
Charles · Jul 29, 2026Machine Learning for Life Scientists: A Practical Methods Guide
Can biologists use machine learning without a CS degree? In 2026, yes — here's what methods actually work…
Charles · Jul 14, 2026Ice Spice: Depression Caused My Weight Loss, Not Ozempic
Ice Spice clarifies her weight loss was due to depression, not Ozempic, raising questions on quick-fix health trends.…
Charles · Mar 7, 2026Hims expansion may not come in time for risky GLP-1 business
Hims' expansion into the GLP-1 market is risky, with timing, regulation, and competition posing challenges. Can they succeed?
Charles · Mar 2, 2026Governing Biotechnology’s Dual-Use Security Dilemma
Exploring the dual-use dilemma in biotechnology, challenges in governance, and the role of technology in ensuring global security.
Charles · Feb 22, 2026